Lung Cancer Considered

Lung Cancer Considered

Por: IASLC
Dr. Stephen Liu and Dr. Narjust Florez host Lung Cancer Considered, the podcast of The International Association for the Study of Lung Cancer (IASLC). IASLC is the only global organization dedicated solely to the study of lung cancer and other thoracic malignancies. Founded in 1974, the association's membership includes more than 6,500 lung cancer specialists across all disciplines in over 100 countries, forming a global network working together to conquer lung and thoracic cancers worldwide. The association also publishes the Journal of Thoracic Oncology, the primary educational and informational publication for topics relevant to the prevention, detection, diagnosis and treatment of all thoracic malignancies. Visit www.iaslc.org for more information.

Lung Cancer considered is funded in part by AstraZeneca, Daiichi Sankyo, Inc., and Takeda
351 episodios disponibles

Latest episodes of the podcast Lung Cancer Considered

Mostrando página 3 de 18

Dr. Bryant Lin Teaching My Cancer 06/05/2025
AACR 2025 Highlights 02/05/2025
What You Should Know About RET-Positive NSCLC: Live from TexasLung25 29/04/2025
Excuse me, What? Top Recommendations for Effective Patient Communication: Live from TexasLung25 22/04/2025
ELCC 2025 Highlights: Insights and Review of the Data 05/04/2025
LCC in Korean: 2024 Lung Cancer Updates 16/03/2025
Virtual Tumor Board: Targeting Residual Disease 16/03/2025
LCC in Mandarin: Virtual Tumor Board - EGFR NSCLC 16/03/2025
LCC in Italian: Virtual Tumor Board - Resectable NSCLC 16/03/2025
The Microbiome and Immunotherapy for Lung Cancer 16/03/2025
Thymus Talk: Unraveling Thymoma and Thymic Carcinoma 15/03/2025
Lung Cancer Considered in Turkish: First-Line Therapies in EGFR Mutant NSCLC 15/03/2025
Live from TTLC25: Lung Cancer and Brain Metastasis 15/03/2025
Lung Cancer Considered in Hungarian: Lung Cancer Treatment Updates 14/03/2025
LCC in Cantonese: WCLC24 Highlights 09/03/2025
Virtual Tumor Board: Stage III ALK+ NSCLC 05/03/2025
Live from TTLC25: Targeted Therapy in Early Stage NSCLC Debate 28/02/2025
The Benefits of Patient Advocacy Groups 24/02/2025
Live from TTLC25: Targeted Therapy in SCLC 20/02/2025
Live from TTLC 2025: Mesothelioma and NUT Carcinoma 20/02/2025
« Primera ‹ Anterior 1 2 3 4 5 ... 18 Siguiente › Última »
© 2003-2025 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA